Skip to main
BTSG

BTSG Stock Forecast & Price Target

BTSG Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 33%
Buy 67%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

BrightSpring Health Services Inc. has demonstrated strong performance in its OP Rehab segment, which has been growing in the double digits and generating attractive margins, positioning the company favorably within the healthcare market. Management anticipates significant improvements in margins over time, further bolstered by strategic mergers and acquisitions that will drive higher EBITDA. The company is also poised for continued growth in its Specialty Pharmacy segment through lower drug costs and operational efficiencies, setting a positive trajectory for earnings estimates in the coming years.

Bears say

BrightSpring Health Services Inc. faces potential revenue challenges as client budget priorities could weaken, adversely impacting the company's business operations. The company's reliance on its Pharmacy Solutions segment raises concerns, particularly if healthcare professionals reduce prescription writing or if drug utilization decreases, which would further affect revenue and cash flow. Additionally, a high debt load may restrict the company's ability to invest in growth, potentially limiting patient expansion opportunities in a competitive healthcare market.

BTSG has been analyzed by 9 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 67% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of BrightSpring Health Services Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About BrightSpring Health Services Inc (BTSG) Forecast

Analysts have given BTSG a Buy based on their latest research and market trends.

According to 9 analysts, BTSG has a Buy consensus rating as of Dec 27, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $41.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $41.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

BrightSpring Health Services Inc (BTSG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.